ABUS Operating Cash Flow Growth
Arbutus Biopharma Corp · Operating Cash Flow Growth
ABUS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported59.09%period ending
ABUS TTM Cash from Operations YoY % (-97.39% → 59.09%)
Year-over-year change
High-resolution chart · PNG
ABUS operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 59.0886% | |
| 41.7161% | |
| 38.879% | |
| 36.9708% | |
| 17.4051% | |
| 24.3603% | |
| 24.5369% | |
| 16.1233% | |
| 11.7116% | |
| 6.4196% | |
| -143.0592% | |
| -125.5188% | |
| -133.7241% | |
| -186.8421% | |
| 47.6456% | |
| 39.6686% | |
| 40.2204% | |
| 46.1063% | |
| -31.2805% | |
| -26.4369% | |
| 3.2714% | |
| 22.911% | |
| 27.554% | |
| 33.3882% | |
| 5.2572% | |
| -8.3715% | |
| -4.6237% | |
| -22.2377% | |
| -1.341% | |
| -26.2675% | |
| -39.5456% | |
| -15.0993% | |
| -21.984% | |
| 20.0492% | |
| 15.9785% | |
| 10.9988% | |
| -9.797% | |
| -34.8641% | |
| -7.8758% | |
| -35.9833% | |
| 1.2188% | |
| -20.1476% | |
| -331.9942% | |
| -1,352.2679% | |
| -83,871.107% | |
| -845.5181% | |
| -84.7758% | |
| -109.6104% | |
| -99.83% | |
| -84.8038% | |
| -120.1339% | |
| 521.035% | |
| 643.5301% | |
| 502.9401% | |
| 543.9423% | |
| 33.1177% | |
| 53.6234% | |
| 5.5249% | |
| 33.13% | |
| -20.9953% | |
| -69.8808% | |
| 4.8478% | |
| -114.6727% | |
| -79.1154% | |
| -3.9488% | |
| -9.7618% | |
| 38.2508% | |
| 10.7576% | |
| -97.3901% |